Clinical Trials Sponsored by ScarX Corp

Total 921 results

WELT corp

Completed

Study of Efficacy of WELT-IP in Insomnia (WCTP-I-B-01)

Insomnia

Korea, Republic of
EyeQue Corp.

Completed

At-home Testing Refraction Results With Best Corrected Visual Acuity (BCVA) Outcomes in Adults

Astigmatism | Myopia | Hyperopia | Visual Impairment

United States
Resverlogix Corp

Completed

Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol

Cardiovascular Disease | Atherosclerosis | Dyslipidemia | Acute Coronary Syndrome

United States
Nevro Corp

Active, not recruiting

Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain (NSRBP)

Back Pain

United States
Metabiomics Corp

Unknown

Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening (PREVENT)

Colorectal Cancer | Colorectal Adenoma
Nevro Corp

Terminated

HF10 Treatment of Chronic Knee Pain (CPSP-3)

Chronic Pain Post-Procedural

United States
Lycera Corp.

Unknown

Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Lycera Corp.

Completed

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Colitis, Ulcerative

United States, Czechia, Hungary, Netherlands, Poland, Serbia, Canada
Metabiomics Corp

Unknown

Metabiomics Colon Cancer Clinical Research Study

Colonic Neoplasms

United States
Archemix Corp.

Terminated

Study of ARC1779 in Patients With Acute Myocardial Infarction Undergoing PCI (vITAL-1)

Acute Myocardial Infarction

Russian Federation
Archemix Corp.

Completed

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

Purpura, Thrombotic Thrombocytopenic | Von Willebrand Disease Type-2b

Austria
Archemix Corp.

Completed

Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers

Thrombosis

United States
SparX Biotech(Jiangsu) Co., Ltd.

Recruiting

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303)

Solid Tumor | CRC | HNSCC | RCC

United States
SCARE (Study group for carbapenem resistance)

Unknown

Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae (COMBAT)

Bloodstream Infection

Turkey
SCARE (Study group for carbapenem resistance)

Unknown

Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients (DETERMINE)

Central Nervous System Infections | Pneumonia, Bacterial | Urinary Tract Infections | Intra-abdominal Infection | Osteomyelitis | Bloodstream Infection | Acute Bacterial Skin and Skin Structure Infection

Turkey
Etnova Therapeutics Corp.

Recruiting

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Liver Cancer

Korea, Republic of
Aqualung Therapeutics Corp.

Not yet recruiting

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

Acute Respiratory Distress Syndrome (ARDS)
Synmosa Biopharma Corp.

Recruiting

Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation

Constipation

Taiwan
GC Biopharma Corp

Recruiting

A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.

Hepatitis B

Korea, Republic of
Turnstone Biologics, Corp.

Recruiting

A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors (STARLING)

Breast Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Uveal Melanoma | Cutaneous Melanoma

United States, Canada
Angion Biomedica Corp

Not yet recruiting

Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)
Healthgen Biotechnology Corp.

Recruiting

Study of OsrhAAT or Placebo in Healthy Volunteers

Emphysema Secondary to Congenital AATD

United States
Healthgen Biotechnology Corp.

Recruiting

A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

Cirrhotic Ascites

China
Sardocor Corp.
Covance

Recruiting

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction (MUSIC-HFrEF1)

Heart Failure | Congestive Heart Failure | Heart Failure, Systolic | HFrEF - Heart Failure With Reduced Ejection Fraction

United States
Chiesi Canada Corp

No longer available

Compassionate Use of Deferiprone in Patients With PKAN

Pantothenate Kinase-Associated Neurodegeneration
Angion Biomedica Corp

Completed

ANG-3070 in Healthy Adult Participants

Healthy Volunteers

Australia
Medicrea, USA Corp.

Withdrawn

Personalized Spine Study Group Registry

Degenerative Disc Disease | Spinal Stenosis | Spinal Fusion | Kyphoscoliosis | Scoliosis; Adolescence | Pseudoarthrosis of Spine | Kyphoses, Scheuermann
Mack Biotech, Corp.

Completed

Airway Clearance System (K031876) Phase IV Device Efficacy

Cystic Fibrosis, Pulmonary

United States
Universal Integrated Corp.

Completed

A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy

Bowel Preparation Before Colonoscopy

Taiwan
Response Biomedical Corp.

Completed

FLU A+B Nasal Swab Clinical Study (FLUA+B)

Influenza

United States, Canada
Sophiris Bio Corp

Completed

Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia (TRIUMPH-1)

Benign Prostatic Hyperplasia

Canada
Sophiris Bio Corp

Completed

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

Prostate Cancer

United States
RXi Pharmaceuticals, Corp.

Unknown

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

Age-related Macular Degeneration | Subfoveal Choroidal Neovascularization | Subretinal Scarring | Subretinal Fibrosis

United States
Ostar Meditech Corp

Completed

Assessment of the Clinical Efficacy of the Heart Spectrum Blood Pressure Monitor for Diagnosis of Atrial Fibrillation

Atrial Fibrillation
Uptake Medical Corp

Completed

Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study

Emphysema

Australia, Ireland, Germany, Austria, New Zealand, United Kingdom
Response Biomedical Corp.

Completed

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care (C-POC)

Myocardial Infarction | Heart Failure | Acute Coronary Syndrome | Congestive Heart Failure

United States
Synta Pharmaceuticals Corp.

Completed

Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors

Solid Tumors

United States
Synta Pharmaceuticals Corp.

Completed

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Melanoma

United States
Synta Pharmaceuticals Corp.

Completed

A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

United States
Synta Pharmaceuticals Corp.

Completed

A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
Uptake Medical Corp

Completed

Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction (BTVA)

Chronic Obstructive Pulmonary Disease | Emphysema

United States
BioMS Technology Corp.

Terminated

Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis (MAESTRO-03)

Multiple Sclerosis, Secondary Progressive
Synta Pharmaceuticals Corp.

Completed

Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

Crohn's Disease

United States, Canada
Synta Pharmaceuticals Corp.

Completed

A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas

Soft Tissue Sarcoma

United States, Canada
Synta Pharmaceuticals Corp.

Completed

STA-5326 in Crohn's Disease Patients

Crohn's Disease

United States
Pasithea Therapeutics Corp.

Recruiting

PAS-004 in Patients With Advanced Solid Tumors

Advanced Solid Tumors | RAS Mutation | NF1 Mutation | RAF Mutation

United States
GC Biopharma Corp

Recruiting

A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting Conditions

Healthy Volunteers

Korea, Republic of
GC Biopharma Corp

Not yet recruiting

An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years

Varicella Zoster Virus Infection
Angion Biomedica Corp

Recruiting

Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

Proteinuria | Glomerular Disease

United States, Australia, Georgia
Bone Biologics Corp

Recruiting

Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis

Degenerative Disc Disease | Spondylolisthesis

Australia

Clinical Trials Sponsored by ScarX Corp

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations